Please login to the form below
medicines use
This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.
Business warning as talk of Brexit ‘No deal’ grows
Asked for its views, a spokesperson for the UK pharma industry association the ABPI said it reiterated its message from 7 December, when the health secretary Matt Hancock issued medicines-specific ... and the need for a significant increase in the use of
Latest news
-
Industry frustrated by late warning on 'no deal' Brexit disruption
Hancock said medicines suppliers should look to use alternative routes in the event of disruption on cross-channel routes, including the use of air freight to fly in supplies. ... roll-off freight capacity and that medicines and medical products will be
-
Digital tech from Autolus and Oxford BioMedica to speed advanced therapies
The three companies will share a £4.3m Digitalisation of Medicines Manufacturing fund from the government Department for Business, Enterprise and Industrial Strategy, (BEIS) which aims to create more efficient and ... Arc Trinova will use new
-
CHMP backs Sanofi’s all-oral sleeping sickness drug
58 mechanism, which gives the CHMP licence to assess and give opinions on medicines that are intended for use in countries outside the EU. ... CHMP round-up. Fexinidazole was one of four new medicines recommended for approval by the CHMP at its meeting
-
AZ’s soon-to-be lung cancer blockbuster Tagrisso approved in Japan
Today’s approval moves the use of Tagrisso to the first-line setting, replacing older medicines which, given the high prevalence of the EGFR mutation in Japan, offers an important new ... The drug is now approved in 40 countries for this indication,
-
Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate
2018. NHS England says its ambition is for the NHS to achieve a recurrent annual saving of £200-300m by 2021 through the increased use of 'best value' biological medicines; this ... It says it has already achieved £210m savings from the use of
More from news
Approximately 0 fully matching, plus 244 partially matching documents found.
Latest Intelligence
-
Happy 70th birthday NHS: the next 70 need to be very different
It also seems to be relatively efficient, with low admin costs and high use of cheaper generic medicines, and also performs well in managing long-term illnesses, such as diabetes. ... That partnership, it is hoped, will create trust – and some
-
30 Women Leaders in UK Healthcare (part 3)
Bucci’s work exemplifies several encouraging trends in healthcare: the development of evidence-based tech for mental health, the use of social enterprise to accelerate progress and the emergence of women ... In 2012 Dr Williams created the GSK Maternal
-
Patient outcomes in practice: delivering value that transforms lives
These questions are central to the premise of medicine optimisation: the ‘person-centric approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines’. ... This should be the goal of pharma and
-
The challenges of making genomics a reality for patients
The Chief Medical Officer’s annual report last year focused on genomics and highlighted that a fundamental shift is required in how new transformative medicines are developed and appraised for use ... Over the next seven years, Vertex anticipates
-
The challenges of making genomics a reality for patients today, not tomorrow
The Chief Medical Officer’s annual report last year focused on genomics and highlighted that a fundamental shift is required in how new transformative medicines are developed and appraised for use ... Over the next seven years, Vertex anticipates
More from intelligence
Approximately 1 fully matching, plus 33 partially matching documents found.
Latest appointments
-
ABPI Scotland appoints Sandra Auld as director
the access to and use of new and innovative medicines for Scottish patients. . ... and innovative medicines.”.
-
EFPIA's Richard Torbett to move to the ABPI
team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions
-
EAHP elects Joan Peppard as president
As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical
-
ABPI appoints value and access manager
Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.
-
Marschall Runge joins Lilly’s board of directors
Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare ... His appreciation of the importance of scientific research,
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
NHS medicines optimisation milestone
by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS
-
Patient Engagement and Experience Conference, 16-17 May
The conference brings together HCPs, patients, payers, government, pharma and industry under one roof to focus on patients’ engagement and experience of their treatment to improve the real-world use of ... medicines.Speaking at the conference .
-
"Legal highs" ruling leaves illegal labs laughing
There is a huge amount of off-label use of licensed medicines by medically qualified prescribers. ... There are also many agents that have crossed the line from illegal to legal use, such as cannabinoids for MS, as well as previously approved medicines
-
Making good practice common practice in rare disease
Good listeners use a number of techniques - here are two simple examples you can try yourself:. ... Researchers found that the size of the drawing predicted speed of return to work, cardiac anxiety, use of alternative medicines and number of phone calls
-
Brexit and Pharma: A match made in hell.
At the start of my career, the Irish Medicines Board (now the HPRA) licenced new products. ... Over the past 22 years, the EMA has been responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
Featured jobs
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Senior Medical Writer
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
-
Senior Account Manager
-
Competitive Salary Offered
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
-
Medical Writer
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Account Manager / Account Director
-
Competative
-
Business Director
-
Competitive Salary Offered
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director
-
Competitive Salary Offered
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
